全球重組蛋白市場（2023-2030）：按產品類型（激素/□）和應用（研究/治療）劃分的規模、份額、增長分析和預測

全球重組蛋白市場規模預計將從2021年的17.5億美元增長到2022年的19.6億美元，預測期內復合年增長率為12%，到2030年將達到41億美元。預計還將增長至8000萬美元。

由於生物技術的進步和對治療性蛋白的需求不斷增加，全球重組蛋白市場正在穩步增長。 重組蛋白是通過基因工程技術生產的，具有高純度和特異性等優點。 這些蛋白質在醫學、研究和診斷等各個領域都有應用。 慢性病的增加和醫療基礎設施投資的增加等因素正在推動市場擴張。 此外，持續的技術進步和有利的政府舉措進一步推動了全球重組蛋白市場的增長。

製藥和生物技術公司不斷增加研發投資，導致資金增加。 近年來，監管要求顯著擴大，為患有血友病和其他出血性疾病等罕見疾病的人提供了更多選擇。

本報告調查了全球重組蛋白市場，提供了市場概況，分析了市場上的各種影響因素、技術和創新趨勢、法律和監管環境、市場規模趨勢和預測、各種分類並總結了區域細分、競爭格局以及主要公司概況。

目錄

• 執行摘要
• 調查方法
• 母公司市場分析
  • 市場概覽
  • 市場規模
  • 市場動態
• 促進因素
• 機會
• 抑制因素
• 作業
• 主要市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 知識產權分析
  • 貿易分析
  • 啟動分析
  • 原材料分析
  • 創新矩陣
  • 管道產品分析
  • 宏觀經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度
• 市場動態和前景
  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 作業
• 監管狀況
• 波特的分析
• Skyquest 對未來顛覆的獨家見解
• 全球重組蛋白市場：按產品類型
  • 市場概覽
  • 荷爾蒙
  • □
  • 抗體
  • 其他
• 全球重組蛋白市場：按應用分類
  • 市場概覽
  • 研究
  • 治療
  • 生物技術
  • 疾病診斷
  • 其他
• 全球重組蛋白市場：按地區
  • 市場概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭狀況
• 排名前 5 名的公司比較
• 主要公司的市場地位
• 各大公司的招聘策略
• 關鍵成功策略
• 近期市場活動
• 主要公司的市場份額
• 主要公司簡介
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (EMD Millipore)
  • Novartis International AG
  • AbbVie Inc.
  • Amgen Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • Johnson & Johnson
  • Sanofi S.A.
  • Biogen Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Gilead Sciences Inc.
  • Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
  • Genentech Inc. (a subsidiary of Roche Holding AG)
  • Regeneron Pharmaceuticals Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.

Global Recombinant Protein Market size was valued at USD 1.75 billion in 2021 and is poised to grow from USD 1.96 billion in 2022 to USD 4.18 billion by 2030, growing at a CAGR of 12% in the forecast period (2023-2030).

The global recombinant protein market is witnessing steady growth due to advancements in biotechnology and increasing demand for therapeutic proteins. Recombinant proteins are produced through genetic engineering techniques, offering advantages such as high purity and specificity. These proteins find applications in various sectors including pharmaceuticals, research, and diagnostics. Factors like rising prevalence of chronic diseases and growing investments in healthcare infrastructure contribute to market expansion. Additionally, ongoing technological advancements and favorable government initiatives further fuel the growth of the global recombinant protein market.

Top-down and bottom-up approaches were used to estimate and validate the size of Recombinant Protein and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The global recombinant protein market is segmented based on product type, application and region. Based on product type the market is categorized into hormone, growth factors, enzymes, antibodies, and others. Based on application the market is categorized into research, therapeutics, biotechnology, disease diagnostic, and others. Based on region, the market segmentation spans North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver

Pharmaceutical and biotechnological companies have consistently increased their investment in research and development, leading to a rise in funding. The past few years have witnessed a significant surge in regulatory requirements, providing more options for individuals with uncommon illnesses like hemophilia and other bleeding disorders.

Restrain

When numerous major players enter a limited market and offer similar products, it triggers price competition. As a result, the prices of these items tend to gradually decrease, thus restricting the growth of the recombinant protein market.

Trend

The antibody segment is expected to experience exponential growth over the projected period. This trend has gained considerable attention in recent years, with numerous companies adopting it for various applications. Following a selection process for antibodies possessing the desired qualities, the genes can be introduced into an expression system to produce large quantities of antibodies.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Recombinant Protein Market by Product Type

• Market Overview
• Hormone
• Enzymes
• Antibodies
• Others

Global Recombinant Protein Market by Application

• Market Overview
• Research
• Therapeutics
• Biotechnology
• Disease Diagnostic
• Others

Global Recombinant Protein Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (EMD Millipore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech Inc. (a subsidiary of Roche Holding AG)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments